GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » Marketable Securities

Ablynx NV (XBRU:ABLXS) Marketable Securities : €288.00 Mil (As of Dec. 2017)


View and export this data going back to . Start your Free Trial

What is Ablynx NV Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ablynx NV's Marketable Securities for the quarter that ended in Dec. 2017 was €288.00 Mil.

Ablynx NV's annual Marketable Securities declined from Dec. 2015 (€230.99 Mil) to Dec. 2016 (€180.48 Mil) but then increased from Dec. 2016 (€180.48 Mil) to Dec. 2017 (€288.00 Mil).

Ablynx NV Marketable Securities Historical Data

The historical data trend for Ablynx NV's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV Marketable Securities Chart

Ablynx NV Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 187.52 192.54 230.99 180.48 288.00

Ablynx NV Semi-Annual Data
Dec07 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 230.99 197.55 180.48 176.50 288.00

Ablynx NV Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Ablynx NV  (XBRU:ABLXS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Ablynx NV Marketable Securities Related Terms

Thank you for viewing the detailed overview of Ablynx NV's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ablynx NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » Marketable Securities
Comparable Companies
SHSE:603233 HKSE:01530 BLUE SHSE:600161 XSWX:BIOEE BPMC NKTR UTHR XTER:MOR IMMU BBIO ADPT ALLK BOM:532523 CRSP ONCE SZSE:002821 LSE:ABC MRTX RGEN
Traded in Other Exchanges
N/A
Address
Website
http://www.ablynx.com
Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV Headlines

No Headlines